Home » Drug Delivery » Injectable Drug Delivery » Autoinjectors to 2024

Autoinjectors to 2024


Chart_Collage_160   Published January 2016  •  Catalog no. AJT322K  •  Price US $3,850


 

Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the introduction and evolution of autoinjectors – devices that are designed to accept a standard prefilled syringe and form an outer user-friendly device package that simplifies the injection process. Autoinjectors enable a significantly larger segment of the patient population to self-administer injectables. This report analyzes eleven important therapeutic segments and examines the impact of autoinjectors on injectable drug markets.
Titles in this Series

Autoinjectors to 2024

Prefilled Syringes

Pen Injectors

Dual Chamber Syringes

High Viscosity Injectables

Bar_Graph      Autoinjectors to 2024 Report Prospectus (Download PDF)

Blue document

A

Autoinjectors to 2024 Report Order Form (Download PDF)


What You Will Learn

• What autoinjectors can be paired with prefilled syringes for injectable drug delivery; what are the key market segments, market dynamics and market demographics?
• What are the therapeutic demand drivers and commercial devices in key product segments?
• What are the design factors, material selection issues, technologies and market development issues?
• How big is the market? How is it growing? What will it look like in 2024?
• Who are the leading injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?
• What is the importance of pharma-device alliances and design partnerships on autoinjector commercialization and market access?
• What is the impact of wirelessly connected autoinjectors on patient care and market growth?
• What are the significant economic, technology, and regulatory factors affecting the market for autoinjectors?


Summary of Contents

Executive Summary

The Market Opportunity

Delivery Market Dynamics
The Economics of Injectable Drugs
What’s Driving the Growth in Autoinjectors?
Prefilled Devices Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors

Autoinjectors – Commercial Devices

Manual Injection Autoinjectors
Automated Injection Autoinjectors
Reusable Autoinjectors
Disposable Autoinjectors
Variable Dose Autoinjectors
Smart Autoinjectors
Product Specific Autoinjectors

Autoinjector Device Design Factors

Material Selection Issues
Part Counts and Device Cost
Safety Features
Needle Insertion Depth
Dose Inspection/Injection Confirmation
Wireless Connectivity
Lyophilized Drugs/Reconstitution
Human Engineering/Ergonomics

Autoinjector Drug Delivery – Therapeutic Sector Analysis

Anaphylaxis/Countermeasures
Anticoagulants
Autoimmune Diseases
Emergency Medicine
Infectious Diseases
Hematopoietics
Hormones
Neurology
Reproductive Health

Market Factors

Regulatory Issues
Device Branding
Patient Compliance and Ease of Use
Healthcare Economics

Company Profiles